THE DISEASE

The name "influenza" originated in the 15th century Italy.  It was then that an epidemic occurred and was called "influence of the stars."  Virologists believe it all starts with birds.  More precisely, water fowl which is defined by virologists as the reservoir for influenza.   They carry almost all known types of influenza, having no ill effects, sharing them with the other animals through their feces.   All animals and human beings that acquire the flu probably get it originally from birds.  Viruses can only infect and take over a cell if the right receptor is present.  As far as present research indicates, humans do not possess the receptor for the avian or bird flu.  Therefore, what’s needed for human infection is another species that has both human and avian flu receptors.  This is where the pig comes into play.  Having both human and avian receptors creates a lot of influenza possibilities for the pig.  The process can be as simple as flu-contaminated bird feces dropping onto dirt in which the pig is rolling around in.  Thus, infecting the pig.  The infection virus is then passed to the farmer.   It is possible for a pig to be infected with one kind of flu(human flu, then contracting the avian flue).  The pig then simultaneously has two different types of  influenza.  When it proceeds to re-infect a human being, it passes on a pig-bird-human influenza. 

It is not possible to get the influenza directly from the bird by inhalation.  Without the proper receptor, it is impossible for the virus to jump species.  However, In Asia and the Orient where we have been hearing about the avian influenza virus being found in humans, one needs to remember that we are talking about cultures where a lot of roosters are used for cock fighting.  It is very possible for those handling the roosters to get scratched and pecked with a little break in the skin which leads to bleeding.  That's one way they can get infected.  Another way is that it is very common for villagers in these developing countries to have roosters, chickens and pigs (their livestock) tied up or running around freely.  A lot of houses are on stilts and the pigs and poultry are tied up under the house.  During cold tropical evenings it is also common to see people sleeping in hammocks, or whatever they use as beds, outside amongst the pigs and the poultry.  This is very common and could very easily explain why we are hearing about humans being infected by the avian influenza overseas.   

Only 10%-20% of the American population that gets sick every year during the "influenza season" actually have the influenza virus.  Other factors are involved such as molds,  fungus, severely compromised immune systems, stress...etc.  The testing of the influenza virus is not common.  Diagnosis is based more on symptoms and less on actually finding the influenza virus in the sick.

THE ANNUAL QUEST

Influenza is that of a mutating virus.  Thus, every year the vaccine viral ingredient changes.  The process in which the Centers for Disease Control and Prevention attempts to predict which influenza viruses will infect people in the United States is based solely on guesswork.     There are three “families” of the influenza viruses WHO and CDC work with: A, B and C.  The C family has never been used to formulate a vaccine because supposedly it is rarely detected in humans. Nor has it ever been associated with an epidemic.   A is the most virulent strain (dangerous and potentially lethal) and C is the least virulent. 

Smith, Andrews and Laidlaw were the first to isolate the A strain.  They found it in ferrets in 1933.  According to the Irish Examiner, it was a British team that found the first virus in a man.  Francis isolated the B virus in 1936.  But from where?  In the same year, Burnet grew the virus on chicken embryos.

After transmission, the virus attaches to and penetrates the respiratory cells which includes the trachea and bronchi.   Then replication of the virus takes place.  Next thing you know, you have a multiplying viral situation resulting in the destruction of the host cells.  The respiratory cells.  This is then followed by the typical symptoms which alert the individual they may have caught an infection.  The incubation period varies from 1-4 days.  The severity of the infection depends on the individuals immune system.   A healthy individual will be able to get rid of it without major complications.   However, the more challenged the immune system already is, the greater risk of serious complications possibly leading to hospitalization and or death.  It is suggested that aspirin not be used to alleviate the symptoms for infants, children or teenagers, because of their risk for developing Reye syndrome.

With these viruses there are two types of proteins (subtypes) which make up the outer protective coating of the viruses:

1. Hemagglutinin (H)

2. Neuraminidase (N)

The viruses chosen for the vaccines are named according to the type of proteins (subtypes)  they carry.   As you see in the chart there are at least fifteen varieties of the (h) and nine of the (n).  These proteins can combine in every possible way to create a strain.  Thus, it is realistically impossible for any scientist to predict what strain will hit the public each year. 

Influenza viruses are cold-adapted.  Therefore they are able to multiply quickly in the mucosa of the nasal area.   A minimum of 48 hours is required to identify symptoms as the result of a viral infection.  Then an additional 1-2 days are needed to identify the virus type.   Physicians contribute this information by telephone on the number of cases and hospitalizations.  A subgroup of physicians swab  from selected cases for confirmation.  Not all suspecting cases are swabbed.   In order to "properly" diagnose an individual as having the influenza infection, it is required for the individual to have a 4-fold rise in antibody titer.   This requires a rapid diagnostic testing for the influenza antigens.     Since these viruses are cold adapted one can correctly assume that they also continue to multiply in the refrigerated vials during shipping and waiting to be inoculated into the human body.

Don’t forget, these viruses are constantly mutating.  That is why it is realistically impossible for scientists to keep up with the mutation because what strains were collected from the previous year have never been conclusively documented to be the very same strain we see infecting individuals in the following year. 

The World Health Organization (WHO) has an international influenza surveillance network to monitor prevalent and new emerging viral strains.  CDC receives weekly reports of influenza activity in America.  These reports are divided into four categories: no cases, sporadic, regional (cases occuring in counties that collectively account for less than 50% of state population), and widespread (cases that collectively account for over 5-% of the state population). Around the world, technicians affiliated with the CDC and WHO collect influenza viruses from pigs and people.  These samples are sent off to the laboratories to be tested.  The most suspecting cases are forwarded to the CDC or to the closest National Influenza Center for full analysis.  CDC then attempts to predict which viruses will infect people in the United States the following year.

It takes time to find chicken eggs deemed “clean”. Meaning that they contain the fewest possible avian contaminants.  The snout of pigs or the nasal area of infected humans are swabbed overseas.  Then those cultures are brought back to the U.S.  Out of these cultures, a "broth" is made which is then injected into fertile chicken eggs that have been stored in incubators.  (Mind you, these are eggs from chickens which are fed rendered animal waste.  They are not your free range healthy chickens).   The eggs are then put back into the incubators where the embryos continue to grow while, at the same time, they are "housing" the three strains of influenza viruses.  The eggs incubate until the embryos are literally teaming with influenza.   Then once the "desired amount" of viruses have been replicated, the embryos are killed and treated with formaldehyde and mercury which are used to kill contaminates and prevent mold growth and further contamination.  There is also aspartame, aluminum hydroxide, antibiotics...etc.  

Because much time is needed to grow the influenza viruses on the chicken embryos later collected for the final manufacturing stages, the realistic scientists can not avoid the fact that this guess work is seriously flawed because viral strains infecting individuals are mutations from the previous years in which strains were obtained.  Is science to assume the common lay person will accept the unproven theory that these strains will help in prevention of infection from the new mutation the following year? 

Physicians brace themselves every year due to anxiety and the reality in which they fear to admit that the vaccine has never been conclusively documented to guarantee any level of immunity.  Even scientists have admitted their lack of confidence for the vaccine to provide immunity.  In the case of the Fujian Influenza it has been stated, “It’s impossible to predict what will happen and, although the Fujian strain was on the radar screen when the decision was made, we didn’t have it in the laboratory. “  At that stage there were question marks over it and I think the correct decision was made to go with the current vaccine.” Dr Jim McMenamin, of the Scottish Centre for Infection and Environmental Health.  How is it possible to  make the "correct decision"  with that kind of information?  It is not.

Directly from CDC:

The following strains will be used in the 2005-2006 influenza vaccine for the U.S.A: The formulation includes two viruses from last year’s vaccine [A/New Caledonia/20/99 (H1N1)-like and B/Shanghai/361/2002-like] and one new virus [A/California/7/2004 (H3N2-like)]. For the A/California/7/2004 (H3N2)-like antigen, manufacturers may use the antigenically equivalent A/New York/55/2004, and for the B/Shanghai/361/2002-like antigen, manufacturers may use the antigenically equivalent B/Jilin/20/2003 virus or B/Jiangsu/10/2003 virus.

Projection for 2005-2006 Influenza Vaccine Supply Compared to 2004-05

According to data provided by the manufacturers, total influenza vaccine production in 2004 was approximately 61 million doses, substantially less than the original number of doses planned by licensed manufacturers. The reduced 2004 production was linked to suspension of Chiron’s license by the British regulatory authority, (MHRA), resulting in a loss of nearly half the projected U.S. supply. For 2005, projections of production remain uncertain. Sanofi pasteur representatives have announced publicly that they plan to produce between 50 and 60 million doses and MedImmune representatives indicate that about 3 million doses of their Live Attenuated Influenza Vaccine (LAIV) will be available. Meanwhile, Chiron’s Liverpool facility is making changes in response to inspectional observations from both MHRA and FDA. If Chiron is able to complete its remediation plan and secure FDA approval, company officials indicate they plan to produce 18-26 million doses for use in the U.S. In late May, GlaxoSmithKline submitted a Biologics License Application to the FDA for its influenza vaccine, and that application is currently under review by the FDA. Company officials have indicated that if their application is approved, they plan to sell about 10 million doses for adults in the U.S.

LETHAL INJECTION

As previously stated, all influenza vaccines  contain Hemagglutinin agents (proteins) of different viruses.  These agents have the ability to cause the red blood cells to clump.  Serious blockage in circulation is a result should clumps form in the blood stream.  When coupled with antibodies against them, Hemagglutinin can block arteries.  Thus, killing cells by the thousands resulting in the lack of oxygen, water and food to vital organs.  The dominating effects ultimately lead to vaccine induced death.

The other toxic molecule is the Neuraminidase.  The other isolated and implemented protein in vaccine manufacturing. Both of these agents are on the the surface of the virus.  The Neuraminidase enzyme in the influenza vaccine is extremely damaging in that it cuts out neuraminic acid from any to all glycoproteins which are essential in cell membranes.

Glycoproteins are complex carbohydrates needed for crucial functions and are in all cell membranes, bones, cartilage, the brain...etc.  They transport vitamins, lipids, minerals and other essential trace elements throughout the body.  They are produced by cells when exposed to invading agents (i.e. viruses, bacteria, experimental chemicals...etc).   Turning into antiviral substances, they are called "interferons" interfering with viral replication.  As described by Dr. Vivian Virginia Vetrano, the public is given false hope and false sense of security which "slash away at you with enzymic knives" instead.

Interestingly enough, pharmaceutical companies claim that the Neuraminidase gives the virus ability to leave the cell.  Yet, how is that possible for the cells having lost their glycoproteins due to the inoculation?  Read more of Dr. Vetrano's detailed description of cellular damage due to inoculation.

A CDC document discusses child deaths during the flu season of 2003-04. It is titled, "Update: Influenza-Associated Deaths Reported Among Children Aged [less than] 18 Years...2003-04 Influenza Season." The report was included in the CDC MMWR Weekly/January 9, 2004.

Listed are so-called co-infections found in these children who were counted as flu deaths in 2003, and one of those co-infections was SERRATIA, the same bacteria said to be contaminating Chiron's Fluvirin vaccine October 2004.

Searching through the VAERS database, there are numerous accounts in which individuals are reported to having been found dead hours to days after the vaccination.

JANUARY 10, 2004. Lawrence Altman, the dean of American medical writers, reports on flu stats for the NY Times. After stating that 93 children have died from the flu this season in the US, Altman states:

"Thirty-three of the victims had not been vaccinated. The disease control agency [CDC] recommends vaccination for all healthy children 6 months and older." 

One should not overlook a very critical part of this piece of news. 60 of the 93 children that died WERE VACCINATED.  In other words, ALL listed CHILDREN  in the article THAT HAD BEEN VACCINATED DIED.  With two thirds of children inoculated for the influenza dead after vaccination,  either the vaccine has such a high failure rate, kills most of it's recipients or both. 

Page 2

The following website is funded by a flu vaccine maker, MedImmune.

This is part of the continuing efforts to convince the public  that there are tens of thousands of healthy children every year that die from the flu.  However, as you further read on the influenza you will see the actual annual death numbers, and that those who died did so because of underlining health problems or medication complications.

The Food and Drug Administration is investigating reports that the deaths of 12 Japanese children may be linked to the anti-viral drug Tamiflu

HOW CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC) WORKS ON THE PUBLIC'S PSYCHE TO GET PEOPLE LINED UP AT THE CLINICS

A word from Dr. Sheri Tenpenny

Step 1: Start discussing the flu at the beginning of the "immunization season."

Posters, fliers and media campaign materials are generally mailed to public health departments and healthcare provider offices in mid-August, "planting the seeds" in the minds of patients so that they request the flu vaccine when it arrives.

Step 2: The media will begin to make pronouncements that the "new" influenza strains anticipated this year "will be associated with severe illness and serious outcomes."

Right on cue, the government announced on Aug. 25, that it is "preparing for world's next big flu outbreak." A report released to the Associated Press suggests that a bad flu season could kill up to 207,000 Americans. To fuel the hysteria, the CDC and Department of Human Services announced that they are issuing a joint "Pandemic Influenza Response and Preparedness Plan" which will stress "ways to speed up vaccine production, limit the spread of a super-flu, and care for the ill."

Step 3: The buildup will continue through the early fall, as local and national "medical experts and public health authorities publicly (e.g., via media) state concern and alarm (by predicting dire outcomes) -- and urge influenza vaccination."

Here's one example: "We know we're going to have a pandemic because, historically, we're overdue for one," said Neil Pascoe, epidemiologist in the infectious disease division of the Texas Department of Health. "When it happens, it's going to be huge. It will be global, and everyone is going to be affected ... it could be terribly fatal. Imagine 4 million Texans [becoming] infected, and 20 percent of them die."

Be prepared for many similar statements in major newspapers and on national TV stations as the weeks progress.

Step 4: Reports from medical experts will be used to "frame the flu season in terms [that will] motivate behavior." Language to be used will include "very severe," "more severe than last or past years" and "deadly."

Last year, there were 1,026 messages sent via the media between September 21-28. Some of the phrases the media used included, "This could be the worst flu season ever," "The flu kills 36,000 people per year" and "The flu shot is the best way to prevent the flu." Even though less than 175 people actually died from influenza in 2003, anticipate exponentially more messages regarding the "deadly flu" will be pushed through the news media this year.

Step 5: Continue to release reports from health officials through the media that influenza is causing severe illness and/or affecting lots of people "helping to foster the perception that many people are susceptible to a bad case of influenza."

Step 6: Give visible, tangible examples of the seriousness of influenza by showing pictures of ill children and affected families who are willing to come forward with their stories. "Show pictures of people being vaccinated, the first to motivate, the latter to reinforce."

Step 7: List references to, and have discussions regarding, the influenza pandemic. "Make continued reference to the importance of vaccination."

The language used to describe Steps 5, 6, and 7 was taken directly from Nowak's presentation. This should leave little doubt the government intends to use the media to create hysteria that will increase the demand for a pharmaceutical product.

Vaccine manufacturers often cry the blues about revenues lost by producing vaccines. However, last year, Chiron, one of the two largest vaccine manufacturers, made 38 million flu shots, accounting for nearly $230 million in revenue. And even though sales of FluMist, the intranasal flu vaccine, reportedly "failed miserably," the company still marked $33 million in revenues from sales of the product. Not exactly the stellar returns

MedImmune had hoped for, but clearly revenues were made.

Health officials are expecting that, through the publicity generated by last year's flu hype, coupled with a carefully planned and implemented new strategy, record numbers will seek vaccination this year. Perhaps, understanding the tactical maneuvers of the "CDC-Big Pharma-Media" partnership will result in another "bust" year for the flu vaccines.

Many thanks to Mrs. Lujene Clark, president of NoMercury.org for her research and bringing this to my attention.